2024-02-20 23:00:16 ET
Image source: The Motley Fool.
AbCellera Biologics (NASDAQ: ABCL)
Q4 2023 Earnings Call
Feb 20, 2024 , 5:00 p.m. ET
Operator
For further details see:
AbCellera Biologics (ABCL) Q4 2023 Earnings Call Transcript2024-02-20 23:00:16 ET
Image source: The Motley Fool.
AbCellera Biologics (NASDAQ: ABCL)
Q4 2023 Earnings Call
Feb 20, 2024 , 5:00 p.m. ET
Operator
For further details see:
AbCellera Biologics (ABCL) Q4 2023 Earnings Call TranscriptMarket Wire News is a media platform, the information on this page was provided by Motley Fool via Quote Media. Read our full disclaimer.
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
News, Short Squeeze, Breakout and More Instantly...
AbCellera Biologics Inc. Company Name:
ABCL Stock Symbol:
Market:
2024-05-08 17:30:13 ET KeyBanc analyst issues OVERWEIGHT recommendation for ABCL on May 8, 2024 02:46AM ET. The previous analyst recommendation was Overweight. ABCL was trading at $3.84 at issue of the analyst recommendation. The overall analyst consensus : BUY. Curr...
2024-05-08 04:30:12 ET Image source: The Motley Fool. AbCellera Biologics (NASDAQ: ABCL) Q1 2024 Earnings Call May 07, 2024 , 5:00 p.m. ET Operator Continue reading For further details see: AbCellera Biologics (ABCL) Q1 2024 Earnings Call Tran...
AbCellera (Nasdaq: ABCL) today announced financial results for the first quarter of 2024. All financial information in this press release is reported in U.S. dollars, unless otherwise indicated. “We continue to execute on advancing our internal pipeline, completing capital investment...